The renin-angiotensin system in blacks: Active, passive, or what?

被引：34

作者：

Price, DA

Fisher, NDL

机构：

[1] Brigham & Womens Hosp, Boston, MA 02115 USA

[2] Harvard Univ, Sch Med, Boston, MA 02115 USA

来源：

CURRENT HYPERTENSION REPORTS | 2003年 / 5卷 / 03期

关键词：

BLOOD-PRESSURE; DIABETIC NEPHROPATHY; RENAL-DISEASE; SERUM ANGIOTENSINOGEN; RACIAL-DIFFERENCES; AFRICAN-AMERICANS; DIETARY-SODIUM; HYPERTENSION; PLASMA; WHITE;

D O I：

10.1007/s11906-003-0025-x

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

Plasma renin activity in blacks has been consistently reported to be lower than in whites. Many mechanisms for the low plasma renin activity have been proposed, including volume status, renal sodium handling, and the reduction of renin release. The status of the RAS is paramount in the regulation of salt and water balance and its implications in disease processes such as hypertension and renal failure. In this review, we present data to suggest that law systemic plasma renin activity in blacks may not be the primary abnormality, but rather the reflection of an overactive RAS at the tissue level in the kidney.

引用

页码：225 / 230

页数：6

共 47 条

[1] End-stage renal disease in the USA: Data from the United States renal data system [J].

Agodoa, LY ;

Jones, CA ;

Held, PJ .

AMERICAN JOURNAL OF NEPHROLOGY, 1996, 16 (01) :7-16

[2] Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].

Agodoa, LY ;

Appel, L ;

Bakris, GL ;

Beck, G ;

Bourgoignie, J ;

Briggs, JP ;

Charleston, J ;

Cheek, D ;

Cleveland, W ;

Douglas, JG ;

Douglas, M ;

Dowie, D ;

Faulkner, M ;

Gabriel, A ;

Gassman, J ;

Greene, T ;

Hall, Y ;

Hebert, L ;

Hiremath, L ;

Jamerson, K ;

Johnson, CJ ;

Kopple, J ;

Kusek, J ;

Lash, J ;

Lea, J ;

Lewis, JB ;

Lipkowitz, M ;

Massry, S ;

Middleton, J ;

Miller, ER ;

Norris, K ;

O'Connor, D ;

Ojo, A ;

Phillips, RA ;

Pogue, V ;

Rahman, M ;

Randall, OS ;

Rostand, S ;

Schulman, G ;

Smith, W ;

Thornley-Brown, D ;

Tisher, CC ;

Toto, RD ;

Wright, JT ;

Xu, SC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728

[3]

ANDERSON NB, 1989, J HYPERTENS, V7, P161

[4] RENAL RENIN-ANGIOTENSIN SYSTEM IN DIABETES - FUNCTIONAL, IMMUNOHISTOCHEMICAL, AND MOLECULAR BIOLOGICAL CORRELATIONS [J].

ANDERSON, S ;

JUNG, FF ;

INGELFINGER, JR .

AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04) :F477-F486

[5]

[Anonymous], 2000, USRDS 2000 ANN DAT R

[6]

Bjorck S, 1990, Scand J Urol Nephrol Suppl, V126, P1

[7] THE SERUM ANGIOTENSINOGEN CONCENTRATION AND VARIANTS OF THE ANGIOTENSINOGEN GENE IN WHITE AND BLACK-CHILDREN [J].

BLOEM, LJ ;

MANATUNGA, AK ;

TEWKSBURY, DA ;

PRATT, JH .

JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (03) :948-953

[8] PROGRESSIVE RENAL-DISEASE - ROLE OF RACE AND ANTIHYPERTENSIVE MEDICATIONS [J].

BRAZY, PC ;

FITZWILLIAM, JF .

KIDNEY INTERNATIONAL, 1990, 37 (04) :1113-1119

[9] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[10]

BRIER ME, 1994, AM J MED SCI, V307, pS38

← 1 2 3 4 5 →